Tulsa, Oklahoma — Tulsa, Oklahoma

Tulsa, Oklahoma is a clinical research site located in Tulsa, Oklahoma, United States 74104.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Tulsa, Oklahoma has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: COVID-19, Diabetic Macular Edema (DME).

Sponsors: Quantum Biopharma, EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tulsa, Oklahoma?

Tulsa, Oklahoma has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tulsa, Oklahoma conducted?

Tulsa, Oklahoma has 2 clinical trials on record, with 1 currently active. Their work covers COVID-19, Diabetic Macular Edema (DME).

Is Tulsa, Oklahoma accredited by Crixeo Health?

Tulsa, Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tulsa, Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.